American Century Companies’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
Other funds holding SPRY
RCM
O
RCMNY
DM
SOCM
American Century Companies's SPRY Position: Q1 2026 in Review
American Century Companies reduced its ARS Pharmaceuticals (SPRY) stake by 6% in Q1 2026, selling an estimated $260K and leaving 428,599 shares worth $3.44M. The position accounts for ﹤0.01% of the portfolio, ranked #1925.
American Century Companies first reported a position in SPRY in Q1 2023 and has held it in 12 quarters since. The position peaked at $5.31M in Q4 2025. 202 funds tracked by Wall St. Rank hold SPRY as of Q1 2026.
- American Century Companies held 428,599 shares of ARS Pharmaceuticals worth $3.44M as of Q1 2026.
- American Century Companies sold 27,167 ARS Pharmaceuticals shares in Q1 2026, an estimated $260K.
- ARS Pharmaceuticals made up ﹤0.01% of American Century Companies's portfolio in Q1 2026, its #1925 holding.
- American Century Companies first reported a position in ARS Pharmaceuticals in Q1 2023 and has held it in 12 quarters since.
- American Century Companies's ARS Pharmaceuticals position peaked at $5.31M in Q4 2025.
- 202 funds tracked by Wall St. Rank held ARS Pharmaceuticals as of Q1 2026.
Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.